Javascript must be enabled to continue!
Abstract FR511: Sucrose elevates blood pressure in mice: a new metabolic model for human hypertension?
View through CrossRef
Introduction:
Sucrose is a disaccharide composed of glucose and fructose linked by an α-1,2-glycosidic bond. It is a major sweetener and the main ingredient in table sugar. There are many cohort studies demonstrating a positive relationship between sweetened beverage consumption and development of hypertension. However, it remains unclear whether sucrose directly regulates blood pressure in mice.
Hypothesis:
Sucrose increases blood pressure and potentially causes hypertension in mice.
Methods:
8~9 weeks old male C57BL6 mice were given 2% sucrose in drinking water. Fresh 2% sucrose drinking water was provided every week. Blood pressure was monitored over 4 weeks using a tail-cuff (CODA Noninvasive Blood Pressure System) and the mice were sacrificed at 4 weeks. The data were compared with no treatment mice and mice with angiotensin II (1000 ng/kg/min) infusion for 4 weeks.
Results:
Systolic blood pressure in mice drinking 2% sucrose water was significantly higher than untreated control mice starting at day 3 and continuing until mice were sacrificed on day 28 (mean systolic blood pressure 157.8±5.0 vs 122.2±3.0 mmHg, day28 p<0.01). Systolic blood pressure in the angiotensin II treated mice also increased starting as day 3 through day 28 (mean systolic blood pressure 177.4±3.6 mmHg at day28). The increase in systolic blood pressure in sucrose treated mice was similar to the increase in the AngII treated mice, until day 14 where the angiotensin II treatment increased systolic blood pressure more than sucrose. Sucrose treatment increased left ventricular mass compared to untreated control mice (116.5±0.66 vs 102.9±0.78 mm3, day28 p<0.05), however, the response to sucrose was not as robust as that elicited by angiotensin II. Sucrose treatment increased fibrotic area around coronary arteries over untreated control mice, which was similar to the response seen in angiotensin II treated mice. Water intake was higher in the sucrose and angiotensin II groups than in the control group (0.221 and 0.209 vs 0.148 ml/mg/day). Average sucrose consumed was 4.42 g/kg/day. There was no significant difference in body weight or blood glucose levels among the 3 groups. However, there was a tendency for higher serum insulin levels in the sucrose group
Conclusions:
Sucrose caused hypertension, cardiac hypertrophy and cardiac fibrosis in mice comparable to the angiotensin II model. Further investigation is necessary to explore potential mechanisms by which sucrose elevates blood pressure in mice.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract FR511: Sucrose elevates blood pressure in mice: a new metabolic model for human hypertension?
Description:
Introduction:
Sucrose is a disaccharide composed of glucose and fructose linked by an α-1,2-glycosidic bond.
It is a major sweetener and the main ingredient in table sugar.
There are many cohort studies demonstrating a positive relationship between sweetened beverage consumption and development of hypertension.
However, it remains unclear whether sucrose directly regulates blood pressure in mice.
Hypothesis:
Sucrose increases blood pressure and potentially causes hypertension in mice.
Methods:
8~9 weeks old male C57BL6 mice were given 2% sucrose in drinking water.
Fresh 2% sucrose drinking water was provided every week.
Blood pressure was monitored over 4 weeks using a tail-cuff (CODA Noninvasive Blood Pressure System) and the mice were sacrificed at 4 weeks.
The data were compared with no treatment mice and mice with angiotensin II (1000 ng/kg/min) infusion for 4 weeks.
Results:
Systolic blood pressure in mice drinking 2% sucrose water was significantly higher than untreated control mice starting at day 3 and continuing until mice were sacrificed on day 28 (mean systolic blood pressure 157.
8±5.
0 vs 122.
2±3.
0 mmHg, day28 p<0.
01).
Systolic blood pressure in the angiotensin II treated mice also increased starting as day 3 through day 28 (mean systolic blood pressure 177.
4±3.
6 mmHg at day28).
The increase in systolic blood pressure in sucrose treated mice was similar to the increase in the AngII treated mice, until day 14 where the angiotensin II treatment increased systolic blood pressure more than sucrose.
Sucrose treatment increased left ventricular mass compared to untreated control mice (116.
5±0.
66 vs 102.
9±0.
78 mm3, day28 p<0.
05), however, the response to sucrose was not as robust as that elicited by angiotensin II.
Sucrose treatment increased fibrotic area around coronary arteries over untreated control mice, which was similar to the response seen in angiotensin II treated mice.
Water intake was higher in the sucrose and angiotensin II groups than in the control group (0.
221 and 0.
209 vs 0.
148 ml/mg/day).
Average sucrose consumed was 4.
42 g/kg/day.
There was no significant difference in body weight or blood glucose levels among the 3 groups.
However, there was a tendency for higher serum insulin levels in the sucrose group
Conclusions:
Sucrose caused hypertension, cardiac hypertrophy and cardiac fibrosis in mice comparable to the angiotensin II model.
Further investigation is necessary to explore potential mechanisms by which sucrose elevates blood pressure in mice.
Related Results
A new mouse model of hypertension using sucrose
A new mouse model of hypertension using sucrose
Sucrose is a disaccharide composed of glucose and fructose linked by an α-1,2-glycosidic bond. It is a major sweetener and the main ingredient in table sugar. Although there are ma...
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Sucrose Metabolism
Sucrose Metabolism
Abstract
Sucrose is one of the main products of photosynthesis in plants, and the most common form of carbohydrate transported from source to si...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives
Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...
[RETRACTED] Guardian Blood Balance Australia- Reviews - Guardian Botanicals Blood Balance [AU] SCAM ALERT! Read Real Critical Reports.. Price in Australia v1
[RETRACTED] Guardian Blood Balance Australia- Reviews - Guardian Botanicals Blood Balance [AU] SCAM ALERT! Read Real Critical Reports.. Price in Australia v1
[RETRACTED]Guardian Blood Balance Australia Reviews - Diabetes and blood sugar are some of the common problems that are attacking so many adult individuals nowadays. Obesity is t...
The role of the alcohol biomarker PEth in hypertension management in primary care
The role of the alcohol biomarker PEth in hypertension management in primary care
<p dir="ltr">Background and aim</p><p dir="ltr">Alcohol increases the risk of developing hypertension and of blood pressure remaining poorly controlled. To preven...
The role of the alcohol biomarker PEth in hypertension management in primary care
The role of the alcohol biomarker PEth in hypertension management in primary care
<p dir="ltr">Background and aim</p><p dir="ltr">Alcohol increases the risk of developing hypertension and of blood pressure remaining poorly controlled. To preven...

